Inhibition of the metabolic degradation of filtered albumin is a major determinant of albuminuria

Julijana Vuchkova, Wayne D Comper

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Abstract

Inhibition of the degradation of filtered albumin has been proposed as a widespread, benign form of albuminuria. There have however been recent reports that radiolabeled albumin fragments in urine are not exclusively generated by the kidney and that in albuminuric states albumin fragment excretion is not inhibited. In order to resolve this controversy we have examined the fate of various radiolabeled low molecular weight protein degradation products (LMWDPs) introduced into the circulation in rats. The influence of puromycin aminonucleoside nephrosis on the processing and excretion of LMWDPs is also examined. The status and destinies of radiolabeled LMWDPs in the circulation are complex. A major finding is that LMWDPs are rapidly eliminated from the circulation (>97 in 2 h) but only small quantities (24 h) due to binding to high molecular weight components in the circulation. If LMWDPs of albumin seen in the urine are produced by extra renal degradation it would require the degradation to far exceed the known catabolic rate of albumin. Alternatively, if an estimate of the role of extra renal degradation is made from the limit of detection of LMWDPs in plasma, then extra renal degradation would only contribute
Original languageEnglish
Article numbere0127853
Number of pages19
JournalPLoS ONE
Volume10
Issue number5
DOIs
Publication statusPublished - 2015

Cite this